Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

Some people with type 1 say these drugs have been game-changers, helping them gain control of wild blood sugar swings for the ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

The scientists found that two medications significantly reduce the risk of developing dementia in life. A new study, ...

The study might worry pregnant people. Here's why experts think you don't need to panic—just keep your blood sugar numbers ...

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Diabetic kidney disease is chronic kidney disease that occurs as a complication of diabetes. Learn about its signs and ...